Trial intelligence / Profile preview

BCG vaccination to Reduce the impact of COVID-19 in healthcare workers (BRACE) Trial

2020-002503-19Phase 3Completed

Sponsor
University Medical Center Utrecht
Start
Jun 2020
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing BCG vaccination with Placebo (2 arms). Primary endpoint: Incidence of COVID-19 disease over 6 months. Started Jun 2020; status: completed.

02

Drugs

bcg vaccine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on 2020-002503-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-002503-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call